SOAT1 and extranodal nasal NK/T cell lymphoma: In addition to the JAK/STAT pathway, other potential therapeutic targets in NKTCL-NT include Aurora kinase, MYC, NF-κB, FOXO3, deletion of chromosome 6q21-25, and promoter hypermethylation [100].